Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Work In Process: 2016-2024

Historic Work In Process for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $13.2 million.

  • Collegium Pharmaceutical's Work In Process fell 33.12% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 33.12%. This contributed to the annual value of $13.2 million for FY2024, which is 95.30% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Work In Process of $13.2 million as of FY2024, which was up 95.30% from $6.7 million recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's Work In Process peaked at $24.7 million during FY2022, and registered a low of $1.0 million during FY2021.
  • Over the past 3 years, Collegium Pharmaceutical's median Work In Process value was $13.2 million (recorded in 2024), while the average stood at $14.9 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Work In Process spiked by 2,350.05% in 2022 and then plummeted by 72.68% in 2023.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's Work In Process stood at $1.1 million in 2020, then decreased by 8.12% to $1.0 million in 2021, then soared by 2,350.05% to $24.7 million in 2022, then crashed by 72.68% to $6.7 million in 2023, then surged by 95.30% to $13.2 million in 2024.